skip to Main Content

Unique Toronto-Based Clinical Trial Reveals new Subtypes of Advanced Pancreatic Cancer

Unique Toronto-Based Clinical Trial Reveals new Subtypes of Advanced Pancreatic Cancer
Researchers at the Ontario Institute for Cancer Research (OICR) and the University Health Network (UHN) have discovered detailed new information about the subtypes of pancreatic cancer. A better understanding of the disease groups may lead to new treatment options and improved clinical outcomes for this lethal disease.

The study, published today in Nature Genetics, represents the most comprehensive analysis of the molecular subtypes of pancreatic cancer to date. Read more . . . 


Back To Top